Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Wolfram C M, Dempke"'
Publikováno v:
Translational Lung Cancer Research. 11:1977-1981
Autor:
Dongliang, Bian, Siming, Jiang, Yicheng, Xiong, Mengfan, Qi, Jiawei, Wu, Alfredo, Addeo, Yoshikane, Yamauchi, Farkhad, Manapov, Wolfram C M, Dempke, Jacopo, Vannucci, Alessandro, Di Federico, Xiaoxiong, Xu, Linsong, Chen
Publikováno v:
Translational Lung Cancer Research. 11:1631-1642
The efficacy of surgery in combination of chemotherapy for stage IIIA small cell lung cancer (IIIA-SCLC) is controversial. The aim of the present study was to analyze the efficacy of surgery combined with chemotherapy, especially in the setting of ne
Autor:
Wolfram C. M. Dempke, Maximilian Desole, Patrizia Chiusolo, Simona Sica, Martin Schmidt-Hieber
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Publikováno v:
Translational lung cancer research. 11(10)
Autor:
Wolfram C. M. Dempke, Klaus Fenchel
Publikováno v:
Transl Lung Cancer Res
Recently approved and highly specific small-molecule inhibitors of c-MET exon 14 skipping mutations (e.g., capmatinib, tepotinib) are a new and important therapeutic option for the treatment of non-small cell lung cancer (NSCLC) patients harbouring c
Autor:
Wenhua, Liang, Kaican, Cai, Qingdong, Cao, Chun, Chen, Haiquan, Chen, Jun, Chen, Ke-Neng, Chen, Qixun, Chen, Tianqing, Chu, Yuchao, Dong, Jiang, Fan, Wentao, Fang, Junke, Fu, Xiangning, Fu, Shugeng, Gao, Di, Ge, Guojun, Geng, Qing, Geng, Jie, He, Jian, Hu, Jie, Hu, Wei-Dong, Hu, Feng, Jiang, Tao, Jiang, Wenjie, Jiao, He-Cheng, Li, Qiang, Li, Shanqing, Li, Shuben, Li, Xiangnan, Li, Yong-De, Liao, Changhong, Liu, Hongxu, Liu, Yang, Liu, Zhuming, Lu, Qingquan, Luo, Haitao, Ma, Xiaojie, Pan, Guibin, Qiao, Shengxiang, Ren, Weiyu, Shen, Yong, Song, Daqiang, Sun, Guangsuo, Wang, Jie, Wang, Mengzhao, Wang, Qiwen, Wang, Wen-Xiang, Wang, Li, Wei, Ming, Wu, Nan, Wu, Hui, Xia, Shi-Dong, Xu, Fan, Yang, Kang, Yang, Yue, Yang, Fenglei, Yu, Zhen-Tao, Yu, Dong-Sheng, Yue, Lanjun, Zhang, Weidong, Zhang, Zhenfa, Zhang, Guofang, Zhao, Jian, Zhao, Xiaojing, Zhao, Chengzhi, Zhou, Qinghua, Zhou, Kunshou, Zhu, Yuming, Zhu, Toyoaki, Hida, Wolfram C M, Dempke, Antonio, Rossi, Marc, de Perrot, Robert A, Ramirez, Mariano, Provencio, Jay M, Lee, Antonio, Passaro, Lorenzo, Spaggiari, Jonathan, Spicer, Nicolas, Girard, Patrick M, Forde, Tony S K, Mok, Tina, Cascone, Jianxing, He
Publikováno v:
Translational lung cancer research. 11(9)
Autor:
Haiquan Chen, Hui Tian, Feng Li, Qi Wang, Xiaojie Pan, Guibin Qiao, Wenjie Jiao, Marc de Perrot, Yang Liu, Dirk De Ruysscher, Erminia Massarelli, Yuming Zhu, Chun Chen, Shuben Li, Rafael Rosell, Raffaele Califano, Wenhua Liang, Antonio Rossi, Toyoaki Hida, Robert A. Ramirez, Ran Zhong, Tao Jiang, Changhong Liu, Nicolas Guibert, Chengzhi Zhou, Qixun Chen, Shengxiang Ren, Haitao Ma, D. Ross Camidge, Steven H. Lin, Massimo Di Maio, Wei Liu, Jian Hu, Junke Fu, Mariano Provencio, Xiaojing Zhao, Jianxing He, Kaican Cai, Li Wei, Deruo Liu, Yi Zhang, Wolfram C. M. Dempke, Song Zhao, Caicun Zhou, Mara B. Antonoff
Publikováno v:
Translational Lung Cancer Research, 9(6), 2696-2715. AME Publishing Company
Translational Lung Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Transl Lung Cancer Res
Translational Lung Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Transl Lung Cancer Res
Lung cancer is the leading cause of cancer-related death worldwide and in China (1). According to the statistics of the National Cancer Center of China, there were 733,300 new cases of non-small cell lung cancer (NSCLC) and approximately 610,200 rela
Autor:
Kirsten Wittling, Andreas Eilers, Wolfram C. M. Dempke, Kirsi Manz, Jonathan Morgan, Klaus Fenchel
Publikováno v:
Advances in Therapy
Introduction This network meta-analysis aims to deliver an up-to-date, comprehensive efficacy and toxicity comparison of the approved first-line tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC) in order to provide support
Autor:
Wolfram C. M. Dempke, Martin Reck
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 159
The transcription factor NRF2 (nuclear factor E2-related factor 2) (also known as nuclear factor, erythroid 2 like 2 [NFE2L2]) is the master regulator of cellular antioxidant responses. NRF2 is repressed by interaction with a redox-sensitive protein
Autor:
Ortrud K. Steinlein, Marlene Reithmair, Zulfiya Syunyaeva, Elke Sattler, Wolfram C. M. Dempke
Publikováno v:
European journal of cancer (Oxford, England : 1990). 151
Objective Birt-Hogg-Dube syndrome (BHDS) is an inherited tumour syndrome characterised by three major symptoms: lung cysts with spontaneous pneumothorax, fibrofolliculoma and renal cell cancer. The first family with this syndrome was described in 197